Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease

European Journal of Pharmacology

Volumn 462, Issue 1-3, 2003, Pages 139-143

  Malinin, Alex I ^a   Atar, Dan ^b   Callahan, Kevin P ^a   McKenzie, Marcus E ^a   Serebruany, Victor L ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Aspirin; Coronary artery disease; Platelet; Receptor

Indexed keywords

ACETYLSALICYLIC ACID; CELL MARKER; GALLIC ACID PROPYL ESTER; MONOCLONAL ANTIBODY; THROMBOCYTE RECEPTOR;

ADULT; ARTICLE; BINDING AFFINITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA ANALYSIS; DEVICE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; LEUKOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TABLET; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 12244255075     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02956-4     Document Type: Article

References (15)

1. Anonymous The Lancet. 1899, July 29;318.
2. Collaborative overview of randomized trials of antiplatelet therapy: I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 308:1994;81-106.
3. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 348:1996;1329-1339.
4. Diener H.C., Cunha L., Forbes C., Sivenius J., Smets P., Lowenthal A. European stroke prevention study: 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J. Neurol. Sci. 143:1996;1-13.
5. Gurbel P.A., Serebruany V.L., Shustov A.R., Ohman E.M., Topol E.J. The GUSTO-III investigators. Global use of strategies to open occluded coronary arteries. Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. J. Am. Coll. Cardiol. 31:1998;1466-1473.
6. Gurbel P.A., Kereiakes D.J., Dalesandro M.R., Serebruany V.L. Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency department. Am. Heart J. 139:2000;320-328.
7. Kundu S.K., Heilmann E.J., Sio R., Garcia C., Davidson R.M., Ostgaard R.A. Description of an in vitro platelet function analyzer - PFA-100. Semin. Thromb. Hemost. 21(Suppl. 2):1995;106-112.
8. Lewis H.D. Jr., Davis J.W., Archibald D.G., Steinke W.E., Smitherman T.C., Doherty J.E. 3rd, Schnaper H.W., LeWinter M.M., Linares E., Pouget J.M., Sabharwal S.C., Chesler E., DeMots H. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N. Engl. J. Med. 309:1983;396-403.
9. Malinin A.I., McKenzie M.E., Horowitz E.D., Oshrine B.R., Barkagan Z.S., Serebruany V.L. Aspirin inhibits GPIIb/IIIa, P-selectin, CD63, and CD107a Surface Receptor expression on Human Platelets. Thromb. Haemost. 86:2001;453.
10. Ruggeri Z.M. New insights into the mechanisms of platelet adhesion and aggregation. Semin. Hematol. 31:1994;229-239.
11. Santos M.T., Moscardo A., Valles J., Martinez M., Pinon M., Aznar J., Broekman M.J., Marcus A.J. Participation of tyrosine phosphorylation in cytoskeletal reorganization, alpha(IIb)beta(3) integrin receptor activation, and aspirin-insensitive mechanisms of thrombin-stimulated human platelets. Circulation. 102:2000;1924-1930.
12. Schwartz K.A., Schwartz D.E., Pittsley R.A., Mantz S.L., Ens G., Sami A., Davis J.M. A new method for measuring inhibition of platelet function by nonsteroidal antiinflammatory drugs. J. Lab. Clin. Med. 139:2002;227-233.
13. Smith J.W., Steinhubl S.R., Lincoff A.M., Coleman J.C., Lee T.T., Hillman R.S., Coller B.S. Rapid platelet-function assay. An automated and quantitative cartridge-based method. Circulation. 99:1999;620-625.
14. Valles J., Santos M.T., Aznar J., Martinez M., Moscardo A., Pinon M., Broekman M.J., Marcus A.J. Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo. Blood. 99:2002;3978-3984.
15. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., Fox K.K. The clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med. 345:2001;494-502.